This week on Walk The Talk, filmed on the sprawling campus of Biocon Ltd., its Chairman and Managing Director, Kiran Mazumdar Shaw speaks on how red-tapism and bureaucracy has crippled India's progress in the Science and Technology sector which is highlighted by the official policies which are very ad-hoc. She comments that her discontentment with the establishment led to Biocon shifting the clinical trials of drugs to the USA and that the last 10 years were "very frustrating" due to many regulatory hurdles. Taxation is another issue stunting Indian Science & Technology as Vietnam, Thailand, Malaysia offer more than just tax relief. Though on an optimistic note she says that India has a lot of potential with respect to Biology and Biotechnology sectors which in turn can help make India a global healthcare industry leader. "Make In India" is an extremely important theme to inspire and encourage high end technological industries.
(Read transcript here)